drug

Adaptation of Motivational Interviewing

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by VA Boston Healthcare System
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

1
Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal
NCT00781755Phase 4Withdrawn

KOLs & investigators

4
James Levitt, M.D.KOL score 5
Professor Gary Donohoe, Ph.D.KOL score 5
Barbara D'Avanzo, Phil.D.KOL score 0
Suzy Bird Gulliver, Ph.D.

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
VA Boston Healthcare System
company
trial
Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal
PHASE4
trial
indication
Schizophrenia
indication
Tobacco Use Disorder
indication
Smoking Cessation
indication
Tobacco Use Disorder
indication
KOL
James Levitt, M.D.
KOL score 5
person
Professor Gary Donohoe, Ph.D.
KOL score 5
person
Barbara D'Avanzo, Phil.D.
KOL score 0
person
Suzy Bird Gulliver, Ph.D.
KOL score —
person